Artwork for podcast Pathfinders in Biopharma
PTC Therapeutics: Building a durable company to benefit patients
Episode 32 • 27th June 2025 • Pathfinders in Biopharma • RBC Capital Markets
00:00:00 00:14:00

Share Episode

Shownotes

A surgeon in burns reconstruction, Matt Klein swapped the operating room for the equally high-pressure environment of drug development. In this episode of Pathfinders in Biopharma, he sets out the vision for the company he now leads, PTC Therapeutics – a pioneer in the field of RNA therapies, now powering towards profitability with treatment candidates for a host of rare diseases.

Follow

Links

Chapters

Video

More from YouTube